<scp>KIFC3</scp> promotes the progression of non–small cell lung cancer cells through the <scp>PI3K/Akt</scp> pathway
KIFC3 lack suppressed the proliferation, invasion, and migration which works, at least partially, by the PI3K/Akt pathway. These findings suggest that targeting KIFC3 via the PI3K/Akt pathway may offer a novel therapeutic strategy for NSCLC.
Authors
- Yu Mu (ORCID: https://orcid.org/0000-0002-0697-6229)
- Haoxiang Liu (ORCID: https://orcid.org/0009-0000-3374-5314)
- Qingxiang Zhang (ORCID: https://orcid.org/0000-0002-4610-4409)
- Anni Luo
Institutions
- Shandong University of Traditional Chinese Medicine (CN)
- Texas Health and Science University (US)
Publication Details
- Journal
- Thoracic Cancer
- Published
- 2024-10-11
- DOI
- https://doi.org/10.1111/1759-7714.15465
- Citations
- 4
- Primary Topic
- Microtubule and mitosis dynamics
- Type
- article
- Field-Weighted Citation Impact
- 1.30